Abstract
Introduction

Zygomycosis is an invasive, opportunistic infection caused by the fungal order Mucorales or Entomophtorales.
It belongs to the Zygomycetes class of true fungi and is characterized by aseptate or nearly aseptate hyphae (1). Zygomycosis is rare, but occurs with increased frequency during chemotherapy-induced prolonged neutropenia and solid organ or bone marrow transplantation. The mortality of zygomycosis remains high (2). Infections due to Mucormycetes include rhinocerebral, pulmonary, cutaneous, gastrointestinal, and disseminated diseases (3, 4). Zygomycosis has a clear affinity for blood vessels, often causing thrombosis and infarction, but cardiac zygomycosis is a rare complication (5-7). However, we present two patients with zygomycosis complications who died of acute myocardial infarction in as-
, leading to a diagnosis of zygomycosis.
F i g u r e 2 . A: P u r p u r i c s k i n l e s i o n s wi t h i n d u r a t i o n , n o d u l e s , p l a q u e s , a n d e c h t h y ma a p p e a r e d o n t h e l o we r e x t r e mi t i e s ( Ca s e 2 ) . B : S k i n b i o p s y s h o ws f u n g a l h y p h a e wi t h wi d e , h y a l i n e , r i b b o n -l i k e , p r e d o mi n a n t l y a s e p t a t e , a n d wi d e -a n g l e d b r a n c h i n g , l o c a t e d b o t h wi t h i n a n a r t e r i a l v e s s e l wi t h a f i b r i n t h r o mb u s ( a r r o w) a n d a r o u n d i t ( a r r o wh e a d s ) ( Ca s e 2 , p e r i o d i c a c i d -S c h i f f s t a i n i n g , × 4 0 ) .
Discussion
Zygomycetes fungi are ubiquitous in nature and can be found on decaying vegetation and in the soil, meaning all humans are exposed to these fungi in their day-to-day activities. The most common route of transmission for Zygomycetes is inhalation of spores from the environment (9) . Specifically in case 2, the patient had contact with soil prior to admission, which might have constituted a route of infection. Therefore, it is essential to get pre-hospital history in detail, especially about the home environment, before initiation of chemotherapy for hematological malignancies.
The diagnosis of zygomycosis relies upon the identification of organisms in tissues by culture and/or histopathological examination, and not upon serological examinations, such as those for serum β-D glucan. In our cases, we identified Zygomycetes hyphae histologically either at autopsy or through a skin biopsy section. In case 1, high serum β-D glucan was noticed and indicated a concurrent infection of Candida albicans confirmed by a sputum culture.
The risk of systemic fungal infection with Zygomycetes increases noticeably during a prolonged neutropenic phase (9, 10) . Disseminated zygomycosis is a rare, usually fatal infectious complication in immunocompromised patients, and constitutes up to 40% of zygomycosis in patients with hematological malignancy (6) (11) . In another report, two cases of cardiac involvement of zygomycosis were documented to have disseminated zygomycosis as well (7) , and all five cases of cardiac zygomycosis had involvement of lungs and other organs in yet another study (12) . It has also been reported that the clinical manifestations of cardiac zygomycosis with predominant myocardial involvement are quite nonspecific (7) . In the present study, case 1 (20) . Liposomal AmB has been shown to be as effective as conventional AmB, but with less infusion-related toxicity, and nephrotoxicity (21) .
In conclusion, cardiac zygomycosis is rare, but should be kept in mind when treating hematologically compromised hosts with complicating life-threatening cardiac diseases, such as AMI or irreversible arrhythmia.
